Clarithromycin-induced long QT syndrome: A case report

dc.contributor.authorCetin M.
dc.contributor.authorYilidrimer M.
dc.contributor.authorÖzen S.
dc.contributor.authorTanrverdi S.
dc.contributor.authorCoskun S.
dc.date.accessioned2024-07-22T08:19:33Z
dc.date.available2024-07-22T08:19:33Z
dc.date.issued2012
dc.description.abstractLong QT syndrome develops for a number of reasons. The number of non-antiarrhythmic drugs reported to induce QT interval prolongation with or without torsade de pointes continues to increase. Clarithromycin is a macrolide antibiotic being increasingly used for the treatment of atypical pneumonia. In this paper, we describe a patient who developed long QT prolongation syndrome after receiving clarithromycin for the treatment of atypical pneumonia. © Copyright 2012 Mecnun Cetin et al.
dc.identifier.DOI-ID10.1155/2012/634652
dc.identifier.issn16879627
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17741
dc.language.isoEnglish
dc.publisherHindawi Limited
dc.rightsAll Open Access; Gold Open Access
dc.subjectclarithromycin
dc.subjectarticle
dc.subjectcase report
dc.subjectchild
dc.subjectdrug withdrawal
dc.subjectheart murmur
dc.subjecthuman
dc.subjectlong QT syndrome
dc.subjectmale
dc.subjectpreschool child
dc.subjectpriority journal
dc.subjectQT interval
dc.subjectQT prolongation
dc.subjectsyncope
dc.subjecttorsade des pointes
dc.subjectvirus pneumonia
dc.titleClarithromycin-induced long QT syndrome: A case report
dc.typeArticle

Files